92683 ⎘
Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
NEW CRYSTALLINE FORM OF L-SERINE AND PROCESS OF PREPARING SAME
#2COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE
#3LIPIDS AND LIPID NANOPARTICLE FORMULATIONS
#4NOVEL AMINO ACID DERIVATIVES
#5TARGETED LNP DELIVERY
#6PROCESS FOR PRODUCING CRYSTALLINE L-CARNITINE
#7PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY
#8LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS
#9METHODS AND IMMUNOGENIC COMPOSITIONS RELATING TO HER2 WITH SELECTIVE SEQUENCE MODIFICATIONS
#10LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING CIRCULAR POLYNUCLEOTIDES
#11LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING CIRCULAR POLYNUCLEOTIDES
#12Lipid nanoparticle compositions for delivering circular polynucleotides
#13INHIBITORS OF AMINO ACID TRANSPORT
#14Picolinamide compounds with fungicidal activity
#15BENZYLAMINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
#16a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#17Lipid compounds and lipid nanoparticle compositions
#18COMPOSITIONS AND METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
#19EFFICIENT PREPARATION OF DOLASTATIN AND AURISTATIN ANALOGS THROUGH A COMMON INTERMEDIATE
#20AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF
#21Immunomodulator compounds
#22CRYSTAL FORM OF AROMATIC VINYL DERIVATIVES, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#23DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases
#24AMINO ACID HAVING FUNCTIONAL GROUP CAPABLE OF INTERMOLECULAR HYDROGEN BONDING, PEPTIDE COMPOUND CONTAINING SAME AND METHOD FOR PRODUCTION THEREOF
#25Calcium BOPTA complex
#26PRODRUGS OF ACYL CARNITINES
#27FABRIC SOFTENER
#28AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION
#29NUCLEIC ACID CONSTRUCT, KIT, DETECTION METHOD, AND THERAPEUTIC EFFECT PREDICTION METHOD
#30Indane-amines as PD-L1 antagonists
#31Picolinamide compounds with fungicidal activity
#32Diphenyl-like Compound, Intermediate Thereof, Preparation Method Therefor, Pharmaceutical Composition Thereof And Uses Thereof
#33Method for preparing L-carnitine using micro-reaction system
#34Solid compositions of cocrystals of cannabinoids
#35H2O CRYSTAL FORMS OF A TCA CYCLE INTERMEDIATE CONJUGATE
#36QUATERNARY AMMONIUM SALTS OF NICOTINIC ACID AND NICOTINAMIDE MONONUCLOETIDES AND RIBOSIDES AS ANTI-AGING AGENTS
#37Preparation and use of high quality esterquats from rice bran fatty acids
#38Biological buffers with wide buffering ranges
#39Tubulysin analogues as anticancer agents and payloads for antibody-drug conjugates and methods of treatment therewith
#40Neprilysin inhibitors
#41Biological buffers with wide buffering ranges
#42Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
#43Immunomodulator compounds
#44NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY
#45COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN RESISTANCE
#46Indane-amines as PD-L1 antagonists
#47Cocrystal of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-l,3-diol
#48PARTICLES FOR THROUGH THE WASH LAUNDRY SOFTENING
#49Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#50Compositions and methods for treating atherosclerotic cardiovascular disease
#51Antifouling zwitterionic polymer coating and reverse coating method
#52COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH ALTERED TCA CYCLE METABOLISM
#53Methods and compositions relating to carnitine-derived materials
#54Picolinamide compounds with fungicidal activity
#55DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
#56Biological buffers with wide buffering ranges
#57CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF
#58Neprilysin inhibitors
#59PICOLINAMIDES WITH FUNGICIDAL ACTIVITY
#60Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
#611-Amino-2-Methyl-2-Propanol Derivatives
#62LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE
#63Indane-amines as PD-L1 antagonists
#64BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS
#65Process for preparing salicyloyl-L-carnitine hydrochloride
#66BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF
#67Crystalline forms
#68Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#69Use of picolinamide compounds as fungicides
#70SALTS OF CARNITINE DERIVATIVES AND METHODS OF PRODUCTION
#71Cell cryopreservation protective composition and use thereof
#72Salts of 5-aminolevulinic acid and derivatives
#73Derivatives of gamma-amanitin
#74LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE
#75Neprilysin inhibitors
#76Compounds as L-cystine crystallization inhibitors and uses thereof
#77Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
#78FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE
#79Picolinamide compounds with fungicidal activity
#80Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#81Bicyclic aryl sphingosine 1-phosphate analogs
#82Compounds for use in treating neuromuscular disorders
#83β-substituted β-amino acids and analogs as chemotherapeutic agents
#84Picolinamides with fungicidal activity
#85Immunomodulator compounds
#86Methods for inhibiting conversion of choline to trimethylamine (TMA)
#87Picolinamides with fungicidal activity
#88Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
#89β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof
#90Neprilysin inhibitors
#91Biological Buffers with Wide Buffering Ranges
#92Use of picolinamide compounds as fungicides
#93Biological Buffers with Wide Buffering Ranges
#94Bicyclic aryl sphingosine 1-phosphate analogs
#95Salts of carnitine derivatives and methods of production
#96Carboxylic acid derivatives and use thereof in the preparation of prodrugs
#97Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
#98Derivatives of polyhydroxy compounds
#99Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
#100Enzymatic process for the preparation of (S)-5-(4-fluoro-phenyl)-5-hydroxy-1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
#101Compounds useful as immunomodulators
#102Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
#103Bicyclic aryl sphingosine 1-phosphate analogs
#104Agent for preventing and/or treating veisalgia
#105Biological buffers with wide buffering ranges
#106Method for preparing (2RS)-amino-(3S)-hydroxy-butyric acid and its derivatives
#107Neprilysin inhibitors
#108Nuclear magnetic resonance diagnostic agent, and method for detecting or diagnosing state of cell, tissue or organ in subject using same
#109Compounds suited as nanocarriers for active agents and their use
#110Chromium 4-hydroxyisoleucinate compound methods for prepartion and use
#111Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof
#112β-substituted β-amino acids and analogs as chemotherapeutic agents
#113Methods for synthesizing amatoxin building block and amatoxins
#114Carboxylic acid ALA esters
#115Beta-amino acid comprising plating formulation
#116Amine compounds and their use as zero or low VOC neutralizers
#117Salts of carnitine derivatives and methods of production
#118INSECTICIDAL LIPID AGENTS ISOLATED FROM ENTOMOPATHOGENIC FUNGI AND USES THEREOF
#119Process for the production of carnitine from β-lactones
#120COMPOUNDS AS L-CYSTINE CRYSTALLIZATION INHIBITORS AND USES THEREOF
#121ANTIMICROBIAL COMPOUNDS AND METHODS OF USE
#122Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#123Versatile and stereospecific synthesis of γ,δ-unsaturated amino acids by Wittig reaction
#124Agent for Preventing and/or Treating Veisalgia
#125Bicyclic aryl sphingosine 1-phosphate analogs
#126Nitric oxide donor compounds
#127Compounds
#128Aspartic resins
#129Prodrugs of fumarates and their use in treating various diseases
#130Prophylactic agent for chronic kidney disease
#131Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates
#132Biological buffers with wide buffering ranges
#133Inhibitors of the shiga toxins trafficking through the retrograde pathway
#134Nitric oxide releasing amino acid ester compound, composition and method of use
#1355-aminolevulinic acid derivatives, methods for their preparation and uses thereof
#136Form of hexyl-5-aminolevulinate hydrochloride and methods of using the same
#137Nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation
#138Cancer heat therapy-enhancing agent
#139Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
#140Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
#141Biological buffers with wide buffering ranges
#142Compounds as L-cystine crystallization inhibitors and uses thereof
#143NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX
#144Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#145Biological buffers with wide buffering ranges
#146Amino Acid Perhydrates, Process for Their Preparation and Uses thereof
#147Addition compounds of guanidinoacetic acid
#148Process for the Preparation of Gadobenate Dimeglumine Complex in a Solid Form
#149Process for reduction of alpha-acyloxy sulfide derivatives
#150Bicyclic aryl sphingosine 1-phosphate analogs
#1515-aminolevulinic acid salt, process for producing the same and use thereof
#152Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
#153Method for the deposition of a metal layer comprising a beta-amino acid
#154Acetylsalicylic acid salts
#155Process for the production of L-carnitine tartrate
#156Arsenic compounds, their preparation methods and uses thereof
#157Process for the recovery of betaines from electrodialysis waste stream
#158PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING
#159Enzymatic process for the preparation of (S)-5-(4-fluoro-phenyl)-5-hydroxy-1morpholin-4-yl-pentan-1-one, an intermediate of Ezetimibe and further conversion to Ezetimibe
#160PROCESS FOR THE PRODUCTION OF CARNITINE FROM BETA-LACTONES
#161Process for the production of carnitine by cycloaddition
#162Method for obtaining optically pure amino acids
#163Process for the hydrogenation of ketoesters
#164Intermediate compounds and their use in preparation of lacosamide
#165INTERMEDIATE COMPOUNDS AND THEIR USE IN PREPARATION OF LACOSAMIDE
#166Process for the production of a fatty acid/carnitine derivative
#167Preparation method of high-purity L-carnitine
#168Process for enantioseparation of chiral systems with compound formation using two subsequent crystallization steps
#169L-carnitine calcium fumarate, preparation method and application for the same
#170Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#171NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE
#172Processes for removal of dibenzofulvene
#173Biological buffers with wide buffering ranges
#174Acid addition salts of 5-aminolevulinic acid or its derivatives
#175Methods for the production of L-carnitine
#176Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
#177Compounds suited as nanocarriers for active agents and their use
#178Additive for aqueous polyurethane dispersion
#179Process for the preparation of intermediates useful in the synthesis of statin derivatives
#180Alanine racemase chiral binaphthol derivative with powerful hydrogen bond donor, and optical resolution and optical transformation methods using the same
#181Compound capable of binding S1P receptor and pharmaceutical use thereof
#182L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same
#183Process for the preparation of betaines
#184Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof
#185BUTYLAMMONIUM MODULATORS OF FATTY ACID TRANSPORT
#186NITRIC OXIDE DONOR COMPOUNDS
#187Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
#188L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX
#189L-threonine derivatives of high therapeutic index
#190PURIFICATION METHOD OF 4-HYDROXYISOLEUCINE
#191Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
#192Process for preparing 3-amino-5-fluoro-4-dialkoxypentanoic acid ester
#193Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester
#194Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
#195L-Threonine derivatives of high therapeutic index
#196Crystal of 5-aminolevulinic acid phosphate and process for producing the same
#197Process for production of a betaine such as carnitine
#198PROCESS FOR THE PREPARATION OF CONTRAST AGENTS
#199AMINO ACID DERIVED PRODRUGS OF PROPOFOL, COMPOSITIONS AND USES THEREOF
#200Method for producing amino acid phosphates
#201L-CARNITINE CALCIUM FUMARATE, PREPARATION METHOD AND APPLICATION FOR THE SAME
#202Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
#203Biological buffers with wide buffering ranges
#204Biological buffers with wide buffering ranges
#205Highly fluorinated β-amino acids and methods of making and using same
#206Tumor imaging compounds
#207Process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives
#208Chemoenzymatic process for the stereoselective preparation of (R)-γ-amino-β-hydroxybutyric acid or (R)-carnitine from 3,4-dihydroxybutanenitrile
#209Amino Acid Derivatives
#210GAMMA-HYDROXYBUTYRATE COMPOSITIONS CONTAINING CARBOHYDRATE, LIPID OR AMINO ACID CARRIERS
#211Imidazolidinone derivative, method of producing the same and method of producing optically active amino acid
#212Unsaturated alkyl esters of 5-aminolevulinic acid, their preparation and their use
#213Intermediate compounds and their use in preparation of lacosamide
#214Amino acid compounds
#215Process for the preparation of contrast agents
#216Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins
#217PROCESS AND COMPOUND
#218Method for producing 5-aminolevulinic acid hydrochloride
#219Alanine racemase chiral binaphthol derivative with powerful hydrogen bond donor, and optical resolution and optical transformation methods using the same
#220Prodrugs of propofol, compositions and uses thereof
#221Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino-3.5-dihydroxyhepanoic acid derivatives and intermediates thereof
#222Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
#223Isoxazoline derivative and novel process for its preparation
#224Methods for the preparation and formulation of l-carnitine valproate salts
#225Non-hygroscopic L-carnitine salts
#226Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
#227Compounds and related methods for mutant p53 reactivation
#228Methods of treating diabetes using carnitine conjugates as dual prodrugs
#229Acetyl L-Carnitine For Preventing Painful Peripheral Diabetic Neuropathy
#230COMPOUNDS AND METHODS OF TREATING METABOLIC SYNDROME AND INFLAMMATION
#231Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
#232Absorbent for separation of carbon dioxide
#233Diagnostic agent for tumor
#234Acid addition salts of 5-aminolevulinic acid or its derivatives
#235Concise β-amino acid synthesis via organocatalytic aminomethylation
#236Organocatalysts and methods of use in chemical synthesis
#2375-Aminolevulinic acid salts and their use
#2385-aminolevulinic acid salt, process for producing the same and use thereof
#239Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
#240Compound capable of binding S1P receptor and pharmaceutical use thereof
#241Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives
#242Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives
#243Carnitine salt, preliposome which contains it and dermocosmetic formula for topical use based upon said carnitine salt
#244Alpha 2 delta ligands for post-traumatic stress disorder
#245L-Threonine derivatives of high therapeutic index
#246Substituted amino acids as erythropoietin mimetics
#247Alpha-ketoglutarates of active ingredients and compositions containing same
#248Compounds with high therapeutic index
#249Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
#250Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
#251Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
#252Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
#253Food and beverages containing L-carnitine derivatives
#254Analogs of 4-hydroxyisoleucine and uses thereof
#255Method for the manufacture of l-threonine-0-(1,1-dimethylethyl)-1,1-dimethylethyl ester
#256Binaphthol derivatives and their use in optical resolution or optical transformation
#257Process for producing optically active β-hydroxy-α-aminocarboxylic acid derivative
#258PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES
#259Method for producing an optically active β-amino acid
#260Amino acid derived prodrugs of propofol, compositions and uses thereof
#2615-azido-laevulinic acid, method for the production thereof and its use
#262Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
#263Compounds and methods for treating insulin resistance and cardiomyopathy
#264Prodrugs of propofol, compositions and uses thereof
#265Bisphenyl compounds useful as vitamin D3 receptor agonists
#266Secondary para-phenylenediamines having a carboxyl group, dye compositions comprising the same, and dyeing processes using the compositions
#267Synthesis of α-amino-β-alkoxy-carboxylic acid esters
#268Watersoluble prodrugs of propofol
#269Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
#270Process for preparing R-(-)carnitine from S-(-)-chlorosuccinic acid or from a derivative thereof
#271Compounds and related methods for mutant p53 reactivation
#272Tumor imaging compounds
#273Methods for producing hydroxy amino acids, esters, and derivatives thereof
#274Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
#275Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
#276Carnitine conjugates as dual prodrugs and uses thereof
#277Hydroxy-amino acids
#278Stable isotope-labeled amino acid and method for incorporating same into target protein
#279Method for preparing (2S, 3R, 4S)-4-hydroxyisoleucine and analogues thereof
#280Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
#281Acid-sensitive polyacetals and methods
#282Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives
#283Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
#284N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists
#285Quinones as disease therapies
#286Fluorogenic calcium ion indicators and methods of using the same